Acquired
Novo Nordisk (Ozempic)
David Rosenthal
Revenue goes from $20 billion in 2019 to $25 in 2021, $30 billion in 2022. And in 2023, so far in the first three quarters that they've reported, it is up another 30% year on year. Of course, with Ben, as you said, years worth of supply constraint demand pipeline.
0
💬
0
Comments
Log in to comment.
There are no comments yet.